Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nav1.8 is a voltage-gated sodium channel subtype highly expressed in nociceptors and plays a critical role in pain signaling. It is tetrodotoxin-resistant and activates at more depolarized potentials with slower inactivation kinetics compared to other sodium channels. Nav1.8 is a promising target for non-opioid analgesics due to its selective expression and central role in pathological pain.
Selective inhibition of Nav1.8, Targeted protein degradation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated sodium channel subtype Nav1.8 (Nav1.8).